Expression patterns of thymosin β4 and cancer stem cell marker CD133 in ovarian cancers

Pathology and Oncology Research

Volumn 19, Issue 2, 2013, Pages 237-245

  Ji, Yong Il ^a,c   Lee, Bo Young ^b   Kang, Yun Jeong ^b   Jo, Jin Ok ^b   Lee, Sang Ho ^a   Kim, Heung Yeol ^a   Kim, Young Ok ^a   Lee, Chulmin ^c   Koh, Suk Bong ^d   Kim, Ari ^e   Lee, Ji Young ^f   Jung, Min Hyung ^g   Ock, Mee Sun ^b   Cha, Hee Jae ^b  

^a Kosin University   (South Korea)

^b Kosin University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Wonkwang University   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

^g Kyung Hee University Hospital   (South Korea)

Author keywords

Cancer stem cells; CD133; Metastasis; Ovarian cancer; Stomach cancer; Thymosin 4

Indexed keywords

CD133 ANTIGEN; THYMOSIN BETA4; TUMOR MARKER;

ARTICLE; CANCER STEM CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MOLECULAR PATHOLOGY; OVARY CANCER; OVARY METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH CARCINOGENESIS; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PEPTIDES; STOMACH NEOPLASMS; THYMOSIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84880703174     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9574-0     Document Type: Article

References (50)

1. Low TL, Goldstein AL (1982) Chemical characterization of thymosin beta 4. J Biol Chem 257:1000-1006
2. Safer D, Golla R et al (1990) Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. Proc Natl Acad Sci U S A 87:2536-2540
3. Safer D, Elzinga M et al (1991) Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 266:4029-4032
4. Cassimeris L, Safer D et al (1992) Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J Cell Biol 119:1261-1270
5. Van Troys M, Dewitte D et al (1996) The actin binding site of thymosin beta 4 mapped by mutational analysis. EMBO J 15:201-210
6. Grant DS, Rose W et al (1999) Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3:125-135
7. Malinda KM, Goldstein AL et al (1997) Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 11:474-481
8. Malinda KM, Sidhu GS et al (1999) Thymosin beta4 accelerates wound healing. J Invest Dermatol 113:364-368
9. Philp D, Nguyen M et al (2004) Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J 18:385-387
10. Philp D, Goldstein AL et al (2004) Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 125:113-115
11. Philp D, St-Surin S et al (2007) Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci 1112:95-103
12. Hall AK (1994) Molecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: a hypothesis. Med Hypotheses 43:125-131
13. Iguchi K, Usami Y et al (1999) Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs. Biochem Pharmacol 57:1105-1111
14. Niu M, Nachmias VT (2000) Increased resistance to apoptosis in cells overexpressing thymosin beta four: a role for focal adhesion kinase pp125FAK. Cell Adhes Commun 7:311-320
15. Moon EY, Song JH et al (2007) Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death. Oncol Res 16:507-516
16. Young JD, Lawrence AJ et al (1999) Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 5:1424-1427
17. Sosne G, Qiu P et al (2007) Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res 84:663-669
18. Larsson LI, Holck S (2007) Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum Pathol 38:114-119
19. Santelli G, Califano D et al (1999) Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 155:799-804
20. Hall AK (1991) Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 48:672-677
21. Ji P, Diederichs S et al (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22:8031-8041
22. Wang WS, Chen PM et al (2004) Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23:6666-6671
23. Kobayashi T, Okada F et al (2002) Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160:869-882
24. Cha HJ, Jeong MJ et al (2003) Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674-1680
25. Huang HC, Hu CH et al (2007) Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26:2781-2790
26. Ricci-Vitiani L, Pagliuca A et al (2008) Colon cancer stem cells. Gut 57:538-548
27. Kondo T, Setoguchi T et al (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101:781-786
28. Ricci-Vitiani L, Lombardi DG et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115
29. Huang EH, Hynes MJ et al (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382-3389
30. Liu G, Yuan X et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
31. Shmelkov SV, Butler JM et al (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-2120
32. Miraglia S, Godfrey W et al (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90:5013-5021
33. Yin AH, Miraglia S et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012
34. Singh SK, Clarke ID et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
35. Singh SK, Hawkins C et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
36. Collins AT, Berry PA et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951
37. Suetsugu A, Nagaki M et al (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351:820-824
38. Yin S, Li J et al (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120:1444-1450
39. Hermann PC, Huber SL et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323
40. Eramo A, Lotti F et al (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
41. O'Brien CA, Pollett A et al (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110
42. Todaro M, Alea MP et al (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1:389-402
43. Steiniger SC, Coppinger JA et al (2008) Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells 26:3037-3046
44. Ricci-Vitiani L, Mollinari C et al (2010) Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J 24:4291-4301
45. Piek JM, van Diest PJ et al (2008) Ovarian carcinogenesis: an alternative hypothesis. Adv Exp Med Biol 622:79-87
46. Bridda A, Padoan I et al (2007) Peritoneal mesothelioma: a review. MedGenMed 9:32
47. Jo JO, Kang YJ et al (2011) Thymosin beta4 expression in human tissues and in tumors using tissue microarrays. Appl Immunohistochem Mol Morphol 19:160-167
48. Vermeulen L, Sprick MR et al (2008) Cancer stem cells-old concepts, new insights. Cell Death Differ 15:947-958
49. Hollier BG, Evans K et al (2009) The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 14:29-43
50. Wang ZY, Zeng FQ et al (2010) Evaluation of thymosin beta4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Urol Oncol 30:167-176